Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05992883 · ClinicalTrials.gov registry record · Phase 3
NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis
A Phase 3 study of Thumb Osteoarthritis, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT05992883: Recruiting Phase 3 study of Thumb Osteoarthritis, sponsored by Mayo Clinic.
NCT05992883 is a Phase 3 study of Thumb Osteoarthritis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 240 participants, above the 66-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (264% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05992883, a Phase 3 study of Thumb Osteoarthritis, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The Researchers are trying to compare two different types of intraarticular injections (injection in the joint) for treating the symptoms of moderate to advanced basilar thumb arthritis. One injection is ketorolac (an NSAID) and the other is triamcinolone (a corticosteroid).
Primary Outcome
Patient-reported VAS score with both motion and rest of the CMC joint. The VAS is a 11-item questionnaire assessing pain. Using a scale of 0 = no pain to 10 = worst pain. Total scores range from 0 - 110, lower scores indicating lower pain and higher scores indicating greater pain.
Conditions Studied
Interventions
- DRUG Ketorolac
- DRUG Triamcinolone
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-07-28 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 3 |
What NCT05992883 shows while recruiting
NCT05992883 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, above the 66-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (264% higher).
The record links to 1 condition, with Thumb Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Ketorolac is the first listed.
NCT05992883 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05992883 about?
NCT05992883 is a clinical study titled "NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis". The Researchers are trying to compare two different types of intraarticular injections (injection in the joint) for treating the symptoms of moderate to advanced basilar thumb arthritis. One injection is ketorolac (an NSAID) and the other is triamcinolone (a corticosteroid).
What is the current status of trial NCT05992883?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2023-07-28. Estimated completion is 2026-12-31.
What conditions does trial NCT05992883 study?
This clinical trial studies the following conditions: Thumb Osteoarthritis.
What interventions are being tested in trial NCT05992883?
The interventions under investigation include: Ketorolac (DRUG), Triamcinolone (DRUG).
Who is sponsoring clinical trial NCT05992883?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05992883 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thumb Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Variable Immobilization Protocol for Arthroplasty of the Carpometacarpal Joint of the Thumb
RECRUITING · NA
-
Turmeric for Patients With Basal Joint Arthritis
RECRUITING · NA
-
Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis
COMPLETED · NA
-
Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI